Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005024 220001973 1.61 null Disease modification (D) 2014-01-21 2014-01-21 LI-1 TRIAL Y N 220027297 TRIAL
220005025 220001974 null 74.4 Curative (C) null 2015-01-21 Trial Unspecified N N 220027299 TRIAL
220005026 220001974 1.63 null Palliative (P) 2018-05-17 2018-06-03 Cytarabine low (10to20mg/m2) IV/SC N N 220027299 CYTARABINE
220005027 220001975 1.69 0 Palliative (P) 2013-05-26 2013-05-31 Cytarabine Low Dose N null 220027303 CYTARABINE
220005028 220001975 1.72 68 Curative (C) 2014-01-08 2014-01-08 Trial Unspecified Y N 220027303 TRIAL
220005029 220001975 0 67.3 Curative (C) 2013-10-13 2013-10-13 LI-1 TRIAL 1 N 220027303 TRIAL
220005030 220018714 null 55 Curative (C) 2015-05-22 2015-05-22 AML17 TRIAL N N 220027313 AML17 TRIAL
220005031 220018714 1.85 77.4 Curative (C) null 2017-07-22 Trial Unspecified Y null 220027313 TRIAL
220005032 220001976 null null Palliative (P) 2014-07-30 2014-07-30 CYTARABINE 2 N 220027315 CYTARABINE
220005033 220001977 null 0 Curative (C) 2014-01-15 2014-01-16 Cytarabine Low Dose 2 N 220027316 CYTARABINE
220005034 220001977 1.71 null Palliative (P) 2015-09-15 2015-09-21 CYTARABINE N N 220027316 CYTARABINE
220005035 220001977 1.7 73 Curative (C) 2014-03-10 2014-03-10 AML17 TRIAL N N 220027316 AML17 TRIAL
220005036 220018715 null null null 2016-04-30 2016-05-01 Cytarabine Low Dose N N 220027320 CYTARABINE
220005037 220018715 null 60 Palliative (P) 2017-08-15 2017-08-15 Trial Unspecified 01 N 220027320 TRIAL
220005038 220021210 1.81 3.3 Palliative (P) 2014-06-13 2014-06-14 Cytarabine Low Dose 02 N 220027327 CYTARABINE
220005041 220001979 1.8 0 Palliative (P) 2014-10-27 2014-10-27 Cytarabine Low Dose N N 220027332 CYTARABINE
220005042 220001979 1.73 73 Curative (C) 2014-12-15 2014-12-17 Trial Unspecified 01 null 220027332 TRIAL
220005043 220015901 1.57 83 Curative (C) 2013-05-19 2013-05-20 AML17 TRIAL N null 220027337 AML17 TRIAL
220005044 220001980 null 70 Curative (C) 2014-08-26 2014-08-26 AML17 TRIAL 1 N 220027345 AML17 TRIAL
220005045 220001980 1.57 null Curative (C) 2015-03-04 2015-03-05 AML17 TRIAL Y N 220027345 AML17 TRIAL
220005046 220001980 null 79.8 Curative (C) 2015-12-01 2015-12-01 CYTARABINE 1 null 220027345 CYTARABINE
220005047 220001980 1.62 null Palliative (P) 2014-02-20 2014-02-22 Cytarabine Low Dose 2 N 220027345 CYTARABINE
220005048 220001981 1.65 null Disease modification (D) 2015-04-25 2015-04-25 AML17 TRIAL 01 N 220027349 AML17 TRIAL
220005049 220001981 1.64 null Palliative (P) null 2016-03-26 Cytarabine Low Dose N N 220027349 CYTARABINE
220005052 220001983 1.8 null Disease modification (D) 2015-04-30 2015-04-30 CYTARABINE 02 null 220027353 CYTARABINE
220005053 220001983 1.54 76 Not known (9) 2011-11-01 2013-08-21 AML17 TRIAL N N 220027353 AML17 TRIAL
220005054 220001983 1.56 null Not known (9) 2013-03-07 2013-03-21 AML17 TRIAL N N 220027353 AML17 TRIAL
220005055 220001984 1.75 26.1 Palliative (P) 2014-12-08 2014-12-08 CYTARABINE null null 220027359 CYTARABINE
220005056 220001985 null 119.8 Curative (C) null 2013-03-13 AML17 TRIAL null null 220027361 AML17 TRIAL
220005057 220001985 0 88.9 Palliative (P) null 2014-10-30 Trial Unspecified Y null 220027361 TRIAL
220005058 220001985 1.55 106 Disease modification (D) 2013-09-27 2013-09-27 Cytarabine low (10to20mg/m2) IV/SC N N 220027361 CYTARABINE
220005059 220001985 1.79 64 Curative (C) 2017-05-21 2017-05-22 AML17 TRIAL 1 null 220027361 AML17 TRIAL
220005060 220001985 1.73 null Curative (C) 2013-08-10 2013-08-13 CYTARABINE N N 220027361 CYTARABINE
220005061 220001985 1.65 77.5 Disease modification (D) 2014-08-05 2014-08-15 AML17 TRIAL 02 N 220027361 AML17 TRIAL
220005062 220001986 null 85.5 Curative (C) 2014-09-22 2014-09-22 AML17 TRIAL Y null 220027371 AML17 TRIAL
220005063 220001987 1.79 119.5 Curative (C) 2015-05-07 2015-05-07 Trial Unspecified 1 null 220027373 TRIAL
220005064 220011045 1.59 46.4 Palliative (P) null 2016-08-15 Cytarabine low (10to20mg/m2) IV/SC 2 Y 220027377 CYTARABINE
220005065 220011045 1.62 81.9 Curative (C) 2013-11-28 2013-11-28 Cytarabine Low Dose N N 220027377 CYTARABINE
220005066 220001988 1.7 null Palliative (P) 2014-05-01 2014-05-02 Cytarabine Low Dose 02 N 220027380 CYTARABINE
220005067 220001989 1.66 89.1 Palliative (P) 2014-06-15 2014-06-15 Trial Unspecified 01 N 220027384 TRIAL
220005068 220001989 null 0 Palliative (P) 2015-04-29 2015-04-29 Cytarabine Low Dose 02 N 220027384 CYTARABINE
220005069 220015906 null 96.2 Not known (9) 2015-10-03 2015-10-06 Trial Unspecified Y N 220027390 TRIAL
220005070 220001990 1.73 86 Curative (C) 2017-06-21 2017-06-23 Cytarabine low (10to20mg/m2) IV/SC N N 220027394 CYTARABINE
220005071 220001990 null 74 Curative (C) 2017-03-25 2017-03-28 AML17 TRIAL Y N 220027394 AML17 TRIAL
220005072 220001991 1.67 78 Curative (C) 2017-08-13 2017-08-13 Trial Unspecified Y N 220027396 TRIAL
220005073 220001991 1.65 75.3 Curative (C) 2016-12-31 2017-01-11 LI-1 TRIAL Y N 220027396 TRIAL
220005074 220001992 1.76 88 Curative (C) 2017-09-04 2017-09-05 AML17 TRIAL 01 N 220027398 AML17 TRIAL
220005075 220001992 1.56 58.8 Palliative (P) 2016-05-19 2016-05-19 Cytarabine Low Dose N N 220027398 CYTARABINE
220005076 220001992 1.5 105 Palliative (P) 2014-01-15 2014-01-18 Cytarabine Low Dose N N 220027398 CYTARABINE
220005080 220018718 null null Curative (C) 2015-04-10 2015-04-22 Cytarabine Low Dose N N 220027410 CYTARABINE